N-1197

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameN-1197

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSodium channels blockers

TargetsSodium channels

Therapy Area/IndicationsHyperlipidemiasHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNisshin Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNisshin Pharma

Active IndicationsN/A

Inactive IndicationsHyperlipidemiasHypertension

ATC CodeN/A